Brent J. Gurney has significant jury trial and other court experience. He recently represented at trial a former regional manager for a medical device manufacturer who was alleged to have participated in a fraudulent off-label marketing scheme. Shortly after opening statements and testimony from the government's first witness in what was projected to be up to a two month federal jury trial, Mr. Gurney convinced prosecutors to drop all charges against Mr. Gurney's client, stating on the record that it no longer considered Mr. Gurney's client to be a co-conspirator. AmericanLawyer.com called the dismissal "quite the dramatic turn." The dismissal was one of five cases featured in "Winning," the National Law Journal’s annual report on significant trial victories. (National Law Journal/www.nlj.com, "Winning," March 12, 2012.)
Among Mr. Gurney’s substantial jury trials is the jury verdict for IGEN that allowed it to terminate its licensing agreement with Roche, IGEN's key business objective, and awarded $505 million in damages. The US Court of Appeals for the Fourth Circuit sustained the termination right, after which Roche purchased IGEN in a $1.25 billion deal. The $505 million jury verdict, which the Fourth Circuit reduced, ranks fourth in the National Law Journal's top verdicts of 2002.
In addition, Mr. Gurney has handled numerous sensitive internal investigations into a wide variety of financial and other matters for clients in the US, Europe, Africa, South America, Asia and the Middle East.
Mr. Gurney also maintains an active pro bono practice. His pro bono work has included a number of matters for military veterans, including a former Navy Seal, and veterans of the Afghanistan and Iraq wars.